S v has a very different model than most accelerators. The two biggest ones are life sciences and hardware. We run effectively fifteen cohorts a year, ten companies and a cohort. And so it's very, very typical for us to just put the the first check. Is actually only about twenty five per cent of the capital that we deploy into all our accelerated companies....
0:42 Jason intros SOSV's Sean O'Sullivan
4:19 How is operating in China during COVID?
5:22 Origin of SOSV, thoughts on in-person accelerators over remote accelerators, why hardware/life-science accelerators need in-person cohorts
9:02 Sean describes SOSV's typical deal terms, unique follow-on strategy & cohort size
14:27 What stage company are SOSV accelerators looking for? Does it vary by industry?
17:58 Sean describes SOSV portfolio company Memphis Meats & how they utilize bioreactors to create cell-based meats
23:06 When will we see plant/cell-based meat being cheaper than the real thing?
29:25 Will the issue of food-availability will be solved in our lifetime?
33:16 Will modern food science revolutionize taste & what is the holy-grail food that will be produced?
42:15 What is being done in the ingredients space?
48:58 How is running an accelerator in China different than running one in the US?
53:39 Embracing hardware, thoughts on Hardware-as-a-Service
1:00:44 Micro-terraforming